Mitra Jelvehgari

researcher

Mitra Jelvehgari is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0003-4247-9681
P1153Scopus author ID22633952600

P69educated atTabriz University of Medical Sciences Faculty of Paramedical SciencesQ101002381
P108employerTabriz University of Medical Sciences Faculty of PharmacyQ99289520
P106occupationresearcherQ1650915

Reverse relations

author (P50)
Q38573478A sight on protein-based nanoparticles as drug/gene delivery systems.
Q36837162Comparative Study of Different Combinational Mucoadhesive Formulations of Sumatriptan-Metoclopramide
Q39081940Comparative study of in vitro release and mucoadhesivity of gastric compacts composed of multiple unit system/bilayered discs using direct compression of metformin hydrochloride
Q41513479Comparison of Different Nanosuspensions as Potential Ophthalmic Delivery Systems for Ketotifen Fumarate.
Q45978369Control of encapsulation efficiency in polymeric microparticle system of tolmetin.
Q42012983Design of vancomycin RS-100 nanoparticles in order to increase the intestinal permeability.
Q41859836Development of a nanoprecipitation method for the entrapment of a very water soluble drug into Eudragit RL nanoparticles.
Q41903629Development of pH-sensitive insulin nanoparticles using Eudragit L100-55 and chitosan with different molecular weights.
Q40965819Effect of formulation and processing variables on the characteristics of tolmetin microspheres prepared by double emulsion solvent diffusion method.
Q42012998Effects of process variables on micromeritic properties and drug release of non-degradable microparticles.
Q92497036Evaluation of anti-inflammatory impact of dexamethasone-loaded PCL-PEG-PCL micelles on endotoxin-induced uveitis in rabbits
Q84498228Evaluation of mechanical and rheological properties of metronidazole gel as local delivery system
Q42012835Experimental Design to Predict Process Variables in the Microcrystals of Celecoxib for Dissolution Rate Enhancement Using Response Surface Methodology.
Q98888460Expert design and optimization of a novel buccoadhesive blend film impregnated with metformin nanoparticles
Q50937909Factors affecting the morphology of benzoyl peroxide microsponges.
Q89457918Formulation and Evaluation of Eudragit RL-100 Nanoparticles Loaded In-Situ Forming Gel for Intranasal Delivery of Rivastigmine
Q37712508Formulation and physicochemical characterization of buccoadhesive microspheres containing diclofenac sodium.
Q84769631Formulation, characterization and in vitro evaluation of theophylline-loaded Eudragit RS 100 microspheres prepared by an emulsion-solvent diffusion/evaporation technique
Q38879581Hydrogel nanoparticles and nanocomposites for nasal drug/vaccine delivery.
Q33488568Micromeritics and release behaviours of cellulose acetate butyrate microspheres containing theophylline prepared by emulsion solvent evaporation and emulsion non-solvent addition method
Q39308820Novel Pentablock Copolymers as Thermosensitive Self-Assembling Micelles for Ocular Drug Delivery
Q40492373Physicochemical and in vitro mucoadhesive properties of microparticles/discs of betamethasone for the management of oral lichen planus.
Q43692134Study of antimicrobial effects of vancomycin loaded PLGA nanoparticles against enterococcus clinical isolates
Q85585978The characteristics and improved intestinal permeability of vancomycin PLGA-nanoparticles as colloidal drug delivery system
Q46855348The microsponge delivery system of benzoyl peroxide: preparation, characterization and release studies.

Search more.